World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 30 March 2015
Main ID:  NCT02273622
Date of registration: 15/10/2014
Prospective Registration: No
Primary sponsor: IMDEA Food
Public title: Human Study of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects
Scientific title: Nutritional Intervention Study to Evaluate the Effect of Hydroxytyrosol on Phase II Enzymes in Healthy Subjects
Date of first enrolment: October 2014
Target sample size: 20
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02273622
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science  
Phase:  N/A
Countries of recruitment
Spain
Contacts
Name:     Francesco Visioli, Prof
Address: 
Telephone:
Email:
Affiliation:  IMDEA Food
Key inclusion & exclusion criteria

Inclusion Criteria:

- Male gender with age range 20-40 years

- Signed patient informed consent

Exclusion Criteria:

- BMI < 19 and >26

- Subjects with a diagnosis of diabetes mellitus, dyslipidemia, hypertension and other
cardiometabolic diseases.

- Subjects with dementia, mental illness or diminished cognitive function.

- Subjects with serious diseases (hepatic, renal, cardiovascular, etc.)

- Subjects who refuse to make the 24 hour urine collection and blood samples under
study.

- Subjects with allergy or intolerance to olive and derivatives.

- Subjects with drug treatment of any kind.

- Current smoking.



Age minimum: 20 Years
Age maximum: 40 Years
Gender: Male
Health Condition(s) or Problem(s) studied
Healthy
Intervention(s)
Dietary Supplement: placebo
Dietary Supplement: hydroxytyrosol
Primary Outcome(s)
Detoxifying potential of hydroxytyrosol and its effects on Phase II enzyme expression (leading to xenobiotics detoxification in the liver). [Time Frame: Change of Baseline and after one week hydroxytyrosol and placebo administration]
Secondary Outcome(s)
Number of participants with change in different anthropometrics parameters [Time Frame: Change of Baseline and after one week hydroxytyrosol and placebo administration]
Number of participants with change in different biochemical parameters [Time Frame: Change of Baseline and after one week hydroxytyrosol and placebo administration]
Concentration of hydroxytyrosol and metabolites in urine [Time Frame: Change of Baseline and after one week hydroxytyrosol and placebo administration]
Secondary ID(s)
IMD PI011
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history